SIP
MBII

Stoneridge Investment Partners’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Stoneridge Investment Partners’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,937
Closed -$14K – 332
2015
Q4 		$14K Sell
12,937
-2,330
-15% -$4.99K ﹤0.01% 275
2015
Q3 		$32K Sell
15,267
-860
-5% -$1.68K ﹤0.01% 277
2015
Q2 		$32K Buy
16,127
+3,354
+26% +$9.51K ﹤0.01% 269
2015
Q1 		$49K Buy
12,773
+460
+4% +$1.7K 0.01% 263
2014
Q4 		$44K Buy
+12,313
New +$32.6K 0.01% 251

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Evanson Asset Management Carmel, California $1.86B AUM 25.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stoneridge Investment Partners's MBII Position: Q1 2016 in Review

Stoneridge Investment Partners sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2016, closing a stake of 12,937 shares — an estimated $14K sold.

Stoneridge Investment Partners first reported a position in MBII in Q4 2014 and held it in 5 quarters. The position peaked at $49K in Q1 2015. 23 funds tracked by Wall St. Rank hold MBII as of Q1 2016.

  • Stoneridge Investment Partners reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2016 after selling out during the quarter.
  • Stoneridge Investment Partners sold 12,937 Marrone Bio Innovations, Inc. shares in Q1 2016, an estimated $14K.
  • Stoneridge Investment Partners first reported a position in Marrone Bio Innovations, Inc. in Q4 2014 and held it in 5 quarters.
  • Stoneridge Investment Partners's Marrone Bio Innovations, Inc. position peaked at $49K in Q1 2015.
  • 23 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2016.

Based on Stoneridge Investment Partners's 13F filing for Q1 2016, filed 29 Apr 2016.